Forecasting The Future: 6 Analyst Projections For Healthcare Realty Trust
Portfolio Pulse from Benzinga Insights
Analysts have mixed ratings for Healthcare Realty Trust (NYSE:HR) with a majority being indifferent. The average 12-month price target has increased to $16.33, reflecting a 4.21% rise. Financial metrics show challenges with negative revenue growth, low net margin, ROE, and ROA, but a favorable debt-to-equity ratio.
July 30, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have mixed ratings for Healthcare Realty Trust with a majority being indifferent. The average 12-month price target has increased to $16.33, reflecting a 4.21% rise. Financial metrics show challenges with negative revenue growth, low net margin, ROE, and ROA, but a favorable debt-to-equity ratio.
The mixed analyst ratings and slight increase in price target suggest a neutral short-term impact. Financial challenges such as negative revenue growth and low profitability metrics are balanced by a favorable debt-to-equity ratio.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100